4.22

0.24% 0.010

Lixte Biotechnology Holdings Inc (LIXT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$4.21

Offen:

$4.31

24-Stunden-Volumen:

85,516

Relative Volume:

0.68

Marktkapitalisierung:

$26.46M

Einnahmen:

Nettoeinkommen (Verlust:

$-4.69M

KGV:

-1.8112

EPS:

-2.33

Netto-Cashflow:

$-3.81M

1W Leistung:

+0.48%

1M Leistung:

-2.31%

6M Leistung:

+222.14%

1J Leistung:

+129.35%

1-Tages-Spanne:

$4.15

$4.40

1-Wochen-Bereich:

$4.01

$4.45

52-Wochen-Spanne:

$0.64

$6.26

Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile

Firmenname

Lixte Biotechnology Holdings Inc

Sektor

Healthcare (1124)

Branche

Biotechnology (627)

Telefon

310 203 2902

Adresse

433 PLAZA REAL, BOCA RATON

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

LIXT's Discussions on Twitter

Vergleichen Sie LIXT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LIXT Lixte Biotechnology Holdings Inc	4.22	26.40M	0	-4.69M	-3.81M	-2.33
VRTX Vertex Pharmaceuticals Inc	444.64	110.88B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	726.21	72.79B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	890.11	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	404.46	54.85B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	189.85	41.41B	447.02M	-1.18B	-906.14M	-6.1812

Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten

Dec 09, 2025

Lixte’s Big Bet: Making Other Cancer Drugs Work Harder - InvestorNews

Dec 09, 2025

Dec 08, 2025

LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities - Yahoo Finance

Dec 08, 2025

Dec 06, 2025

Lixte Biotechnology (LIXT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 06, 2025

Meme Stocks: Will Lixte Biotechnology Holdings Inc stock maintain momentum in 2025Quarterly Trade Report & Free Weekly Watchlist of Top Performers - BỘ NỘI VỤ

Dec 06, 2025

Dec 05, 2025

Lixte Biotechnology shares slide following purchase of UK-based Liora - MSN

Dec 05, 2025

Is Lixte Biotechnology Holdings Inc. (8640) stock a buy on weaknessWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser

Dec 05, 2025

Will Lixte Biotechnology Holdings Inc. stock maintain momentum in 2025Market Trend Summary & Daily Oversold Stock Bounce Ideas - Newser

Dec 05, 2025

Dec 04, 2025

What sentiment indicators say about Lixte Biotechnology Holdings Inc. stockJuly 2025 EndofMonth & Fast Momentum Entry Tips - Newser

Dec 04, 2025

Is Lixte Biotechnology Holdings Inc. (8640) stock undervalued historicallyQuarterly Trade Summary & Real-Time Volume Surge Alerts - Newser

Dec 04, 2025

Can Lixte Biotechnology Holdings Inc. stock deliver consistent earnings growthJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser

Dec 04, 2025

Will Lixte Biotechnology Holdings Inc. (8640) stock rise with strong economy2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser

Dec 03, 2025

Nov 27, 2025

There is no doubt that Lixte Biotechnology Holdings Inc (LIXT) ticks all the boxes. - Setenews

Nov 27, 2025

Nov 25, 2025

Lixte Biotechnology Acquires Liora Technologies for Growth - TipRanks

Nov 25, 2025

LIXTE Biotechnology acquires UK-based proton therapy developer Liora By Investing.com - Investing.com Nigeria

Nov 25, 2025

Lixte Biotechnology stock falls after acquiring UK-based Liora By Investing.com - Investing.com

Nov 25, 2025

Lixte Biotechnology stock falls after acquiring UK-based Liora - Investing.com

Nov 25, 2025

LIXTE Biotechnology (LIXT) Expands with Acquisition of Liora Tec - GuruFocus

Nov 25, 2025

LIXTE Biotechnology acquires UK-based proton therapy developer Liora - Investing.com India

Nov 25, 2025

LIXTE Biotechnology Holdings, Inc. Completes Acquisition of Liora Technologies Europe Ltd. to Advance Proton Therapy Treatment for Cancer - Quiver Quantitative

Nov 25, 2025

LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment - InvestorNews

Nov 25, 2025

S&P 500, Dow and NASDAQ end day on positive note as Wall Street begins Thanksgiving week on high with boos - The Economic Times

Nov 25, 2025

Nov 24, 2025

Lixte Biotechnology announces $5M equity financing; shares down - MSN

Nov 24, 2025

Nov 23, 2025

Will Upside Catalysts Materialize for Vallabh Steels Limited in YEARGrowth Stock Opportunities & Small Capital Investment Tips - earlytimes.in

Nov 23, 2025

Nov 21, 2025

Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants By Investing.com - Investing.com Australia

Nov 21, 2025

Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants - Investing.com UK

Nov 21, 2025